logo

Arsanis, Inc. (ASNS)



Trade ASNS now with
  Date
  Headline
8/13/2018 8:10:58 AM Arsanis Q2 Net Loss $12.1 Mln Or $0.85 Per Share
6/28/2018 7:12:27 AM Arsanis Announces Discontinuation Of Its Phase 2 Clinical Trial Of ASN100
6/28/2018 7:10:38 AM Arsanis, Trading Expected To Resume At 7:30 AM ET
6/28/2018 7:02:01 AM Arsanis, Trading Halted Pending News
5/10/2018 7:07:26 AM Arsanis Q1 Net Loss $10.6 Mln Or $0.74/shr Vs. Net Loss $5.4 Mln Or $10.49/shr Last Year
3/14/2018 8:04:53 AM Arsanis Secures Key Patents For ASN100 Covering Cross-Neutralizing S. Aureus Toxin Antibodies
3/9/2018 7:17:55 AM Arsanis Q4 Net Loss $11.2 Mln Or $1.68/Shr Vs Loss Of $5.3 Mln Or $10.37/Shr Last Year